FDA Investigator Josh Renzon Ramilo
Josh Renzon Ramilo has inspections in 2 countries as of 03 Aug 2023. Josh Renzon Ramilo has collaborated with a combinined 916 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
03 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Alice S Tsao,
Allen Lou,
Amatul H Marium,
Amit Kokate,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Anthony J Donato,
Bijoy Panicker,
Daniel J Grabicki,
Douglas C Kovacs,
Erik W Koester,
Erin D Mccaffery,
Frederick Razzaghi,
Gam S Zamil,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
Jazmine N Brown,
Jessica S Estriplet,
Jill M Sooter,
Jill Mielziner,
Jose M Cayuela,
Juanita P Versace,
Karen E D'orazio,
Karishma G Gopaul,
Kelli F Dobilas,
Kenneth M Gordon,
Kristy A Zielny,
Larry Johnson,
Lawrence R Johnson,
Li Li,
Marcia D Fields,
Margaret M Sands,
Maria Estrella,
Marisa R Eschmann,
Masfin Abdi,
Michael R Klapal,
Monika Borkowska,
Nancy F Scheraga,
Niketa Patel,
Paul L Bellamy,
Peter R Lenahan,
Regina T Brown,
Rose Ljean Mary,
Russell J Glapion,
Samir C Gala,
Sony Mathews,
Stephen J Mottola,
Unnee Ranjan,
William J Leonard,
Yvesna C Blaise,
Zakaria I Ganiyu,
Zhe J Tang
Josh Renzon Ramilo's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2023 | FDA 483 | SOFIE Co. dba SOFIE - Form 483, 2023-01-20 |
September, 2022 | EIR | New Jersey Laboratories - EIR, 2022-09-22 |
November, 2022 | FDA 483 | Pharmacy Innovations - Form 483, 2022-11-30 |
September, 2022 | FDA 483 | New Jersey Laboratories - Form 483, 2022-09-22 |
September, 2022 | FDA 483 Response | New Jersey Laboratories - Form 483R, 2022-09-22 |
March, 2023 | FDA 483 | Saptalis Pharmaceuticals LLC - Form 483, 2023-03-17 |
August, 2023 | FDA 483 | Inopak Ltd - Form 483, 2023-08-03 |
January, 2024 | FDA 483 | First Time US Generics LLC - Form 483, 2024-01-12 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more